Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir

Qi Peng(Chinese Academy of Sciences), Yi Shi(Chinese Academy of Medical Sciences & Peking Union Medical College), Jianxun Qi(Chinese Academy of Sciences), Min Wang(Central South University), Jingru Zhao(Institute of Microbiology), Ruchao Peng(Institute of Microbiology), Bin Yuan(China Academy of Chinese Medical Sciences), Lifeng Fu(Chinese Academy of Sciences)
The Innovation
January 18, 2021
10.1016/j.xinn.2021.100080
Cited by 86

Related Papers

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
|Nature Genetics|2014|780
Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA
|Cell Death and Differentiation|2019|582
Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2
|Cell|2022|538
Enabling the 'host jump': structural determinants of receptor-binding specificity in influenza A viruses
|Nature Reviews Microbiology|2014|312
Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2
|Cell Reports|2020|281